ConductScience.org, home

Paper40246777

Therapeutic options for human papillomavirus-positive tonsil and base of tongue cancer.

Zupancic M and 3 others. J Intern Med, 2025. Cited by 7 papers, by iCite.

Cite this record

ConductScience Library. Therapeutic options for human papillomavirus-positive tonsil and base of tongue cancer. Papers, record 40246777. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40246777

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Therapeutic options for human papillomavirus-positive tonsil and base of tongue cancer.
PubMed
Journal
J Intern Med
PubMed
Year
2025
PubMed
Publication types
Journal Article, Review, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
7
iCite
Relative citation ratio, by iCite
2.12, provisional
iCite
Revised in PubMed
2026-05-16
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Zupancic MMark
2Kostopoulou ONOurania N
3Marklund LLinda
4Dalianis TTinahttps://orcid.org/0000-0001-7022-2424

Source PubMed

Download CSV of authors

Topics9

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Tongue NeoplasmsMajor topic
Papillomavirus InfectionsMajor topic
Tonsillar NeoplasmsMajor topic
Squamous Cell Carcinoma of Head and NeckMajor topic
Carcinoma, Squamous CellMajor topic
Humans
Papillomaviridae
Immune Checkpoint Inhibitors
Human Papillomavirus Viruses

Source PubMed

Download CSV of topics

Grants3

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
232700PJSwedish Cancer FoundationPubMed
Karolinska InstitutetPubMed
Not applicableStockholm City CouncilPubMed

Source PubMed

Download CSV of grants

References196

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
127699545Update on De-intensification and Intensification Studies in HPV.Recent Results Cancer Res2017https://conductscience.org/library/papers/27699545PubMed
235431082Longitudinal measurement of HPV copy number in cell-free DNA is associated with patient outcomes in HPV-positive oropharyngeal cancer.Eur J Surg Oncol2022https://conductscience.org/library/papers/35431082PubMed
325091798De-escalation treatment protocols for human papillomavirus-associated oropharyngeal squamous cell carcinoma: a systematic review and meta-analysis of current clinical trials.Eur J Cancer2014https://conductscience.org/library/papers/25091798PubMed
430584688Changes in incidence and prevalence of human papillomavirus in tonsillar and base of tongue cancer during 2000-2016 in the Stockholm region and Sweden.Head Neck2019https://conductscience.org/library/papers/30584688PubMed
532928035Communicative Participation and Quality of Life in Pretreatment Oral and Oropharyngeal Head and Neck Cancer.Otolaryngol Head Neck Surg2021https://conductscience.org/library/papers/32928035PubMed
629587383Protein Expression in Tonsillar and Base of Tongue Cancer and in Relation to Human Papillomavirus (HPV) and Clinical Outcome.Int J Mol Sci2018https://conductscience.org/library/papers/29587383PubMed
725993150Targeting the PI3K Pathway in Head and Neck Squamous Cell Carcinoma.Am Soc Clin Oncol Educ Book2015https://conductscience.org/library/papers/25993150PubMed
815386365Human papillomavirus is more common in base of tongue than in mobile tongue cancer and is a favorable prognostic factor in base of tongue cancer patients.Int J Cancer2004https://conductscience.org/library/papers/15386365PubMed
933425717The Tumor Microenvironment and Immunotherapy of Oropharyngeal Squamous Cell Carcinoma.Front Oncol2020https://conductscience.org/library/papers/33425717PubMed
1031788102In vitro antitumor effects of FGFR and PI3K inhibitors on human papillomavirus positive and negative tonsillar and base of tongue cancer cell lines.Oncol Lett2019https://conductscience.org/library/papers/31788102PubMed
1118172269Induction of tumor-specific CD4+ and CD8+ T-cell immunity in cervical cancer patients by a human papillomavirus type 16 E6 and E7 long peptides vaccine.Clin Cancer Res2008https://conductscience.org/library/papers/18172269PubMed
1231838340Validation and characterisation of prognostically significant PD-L1+ immune cells in HPV+ oropharyngeal squamous cell carcinoma.Oral Oncol2020https://conductscience.org/library/papers/31838340PubMed
1327718784Nivolumab for Recurrent Squamous-Cell Carcinoma of the Head and Neck.N Engl J Med2016https://conductscience.org/library/papers/27718784PubMed
1426095926The role of HPV RNA transcription, immune response-related gene expression and disruptive TP53 mutations in diagnostic and prognostic profiling of head and neck cancer.Int J Cancer2015https://conductscience.org/library/papers/26095926PubMed
1528029303
E1308: Phase II Trial of Induction Chemotherapy Followed by Reduced-Dose Radiation and Weekly Cetuximab in Patients With HPV-Associated Resectable Squamous Cell Carcinoma of the Oropharynx- ECOG-ACRIN Cancer Research Group.
J Clin Oncol2017https://conductscience.org/library/papers/28029303PubMed
1619330833Incidence of human papillomavirus (HPV) positive tonsillar carcinoma in Stockholm, Sweden: an epidemic of viral-induced carcinoma?Int J Cancer2009https://conductscience.org/library/papers/19330833PubMed
1725631445Comprehensive genomic characterization of head and neck squamous cell carcinomas.Nature2015https://conductscience.org/library/papers/25631445PubMed
1836228746Safety of Nivolumab Added to Chemoradiation Therapy Platforms for Intermediate and High-Risk Locoregionally Advanced Head and Neck Squamous Cell Carcinoma: RTOG Foundation 3504.Int J Radiat Oncol Biol Phys2023https://conductscience.org/library/papers/36228746PubMed
1928720154Human papillomavirus tumour status is not associated with a positive depression screen for patients with oropharyngeal cancer.J Laryngol Otol2017https://conductscience.org/library/papers/28720154PubMed
2032771994CD163+ cytokine-producing cDC2 stimulate intratumoral type 1 T cell responses in HPV16-induced oropharyngeal cancer.J Immunother Cancer2020https://conductscience.org/library/papers/32771994PubMed

See all 196 referencesDownload CSV of references

Cited by6

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 7 citations.

PMIDTitleJournalYearIn PapersSource
42626754Case Reports of Four Patients with HPV-Positive Head and Neck Cancer of Non-Oropharyngeal Origin Undergoing Liquid Biopsy for Circulating Cell-Free HPV-DNA before, during, and after Treatment.Case Rep Oncol2026https://conductscience.org/library/papers/42626754PubMed
42471999Dual targeting of PI3K and FGFR or CDK4/6 reveals synergistic responses in HPV-positive and HPV-negative oropharyngeal cancer spheroids.Mol Ther Oncol2026https://conductscience.org/library/papers/42471999PubMed
41972830What If Trojan Horse Nanoparticles Could Change the Game for HPV Gene-Targeted Therapies?J Med Virol2026https://conductscience.org/library/papers/41972830PubMed
41890267HPV-positive cancers at uncommon sites: a narrative review.Oncol Rev2026https://conductscience.org/library/papers/41890267PubMed
41419643Circulating cell free HPVDNA in HPV positive head and neck cancer reveals fast responders and early peakers during treatment.Sci Rep2025https://conductscience.org/library/papers/41419643PubMed
40246777Therapeutic options for human papillomavirus-positive tonsil and base of tongue cancer.J Intern Med2025https://conductscience.org/library/papers/40246777PubMed

Download CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
CD8A925PubTator's text mininghttps://conductscience.org/library/genes/925

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/40246777

GET https://conductscience.org/api/papers/v1/40246777/references?page=2